Sign Out
Capsule: It should not be given to the petit mal patients because it can exacerbate the attack.
Sudden termination of treatment in patients with epilepsy can lead to status epilepticus.
Administration in pregnant women with consideration of the possibility congenital malformations, neonatal defects coagulation and haemorrhage in newborns.
Caution when used in patients with liver dysfunction and in elderly patients.
Phenytoin not indicated for attack that caused by hipoglikemia.
During take this medicine don't drive motor vehicle or run engine.
Caution when used in patients with blood dyscrasia.
Stop the treatment if there is "skin rash".
Phenytoin may interfere with vitamin D metabolism and can lead to osteomalacia.
Not recommended administration in lactating women, due to phenytoin excreted through breast milk.
Injection: Abrupt withdrawal of Phenytoin in epileptic patients may precipitate status epilepticus.
Dosage reduction, discontinuation or substitution of alternative anticonvulsant medication should be done gradually.
Intravenous administration should not exceed 50 mg (1 ml solution) per minute in adults. Do not use solutions that are hazy or contain precipitates.
The drug should be used with caution in patients with impaired liver function or blood dyscrasia
During the usage of this drug. It is prohibited to drive vehicle or work with machinery.
Phenytoin is not indicated for seizures due to hypoglycemic or other causes that are not known with certainty.
